- Home
- COMM vs APGE Comparison
COMM vs APGE Comparison
Compare COMM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- APGE
- Stock Information
- Founded
- COMM 1976
- APGE 2022
- Country
- COMM United States
- APGE United States
- Employees
- COMM N/A
- APGE N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COMM Technology
- APGE Health Care
- Exchange
- COMM Nasdaq
- APGE Nasdaq
- Market Cap
- COMM 1.8B
- APGE 2.0B
- IPO Year
- COMM 2013
- APGE 2023
- Fundamental
- Price
- COMM $15.50
- APGE $37.29
- Analyst Decision
- COMM Hold
- APGE Strong Buy
- Analyst Count
- COMM 6
- APGE 4
- Target Price
- COMM $10.30
- APGE $97.50
- AVG Volume (30 Days)
- COMM 10.7M
- APGE 576.9K
- Earning Date
- COMM 08-04-2025
- APGE 08-11-2025
- Dividend Yield
- COMM N/A
- APGE N/A
- EPS Growth
- COMM N/A
- APGE N/A
- EPS
- COMM 3.34
- APGE N/A
- Revenue
- COMM $4,751,500,000.00
- APGE N/A
- Revenue This Year
- COMM $21.14
- APGE N/A
- Revenue Next Year
- COMM $8.73
- APGE N/A
- P/E Ratio
- COMM $37.17
- APGE N/A
- Revenue Growth
- COMM 20.87
- APGE N/A
- 52 Week Low
- COMM $2.94
- APGE $26.20
- 52 Week High
- COMM $15.85
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- COMM 80.25
- APGE 46.88
- Support Level
- COMM $14.65
- APGE $36.74
- Resistance Level
- COMM $15.85
- APGE $38.92
- Average True Range (ATR)
- COMM 0.82
- APGE 1.78
- MACD
- COMM 0.34
- APGE 0.07
- Stochastic Oscillator
- COMM 95.82
- APGE 53.44
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.